Section 4
Chapter 3,472

In vitro activity of the new triazole BMS-207147 against Aspergillus species in comparison with itraconazole and amphotericin B

Moore, C.B.; Walls, C.M.; Denning, D.W.

Antimicrobial Agents and ChemoTherapy 44(2): 441-443


ISSN/ISBN: 0066-4804
PMID: 10639380
DOI: 10.1128/aac.44.2.441-443.2000
Accession: 003471891

Download citation:  

The in vitro activity of BMS-207147 against 80 clinical isolates of Aspergillus (50 A. fumigatus and 10 each of A. terreus, A. flavus and A. niger) was compared with that of itraconazole and amphotericin B, using a validated microtitre method. Geometric mean minimum inhibitory concentrations (MICs in micro g/ml) were as follows: 1.71 for BMS-207147, 0.67 for itraconazole and 0.63 for amphotericin B. The range of concentrations of each drug was 0.125 to >16 micro g/ml.

PDF emailed within 0-6 h: $19.90